Indomethacin serum concentrations in man. Effects of dosage, food, and antacid
- PMID: 970990
- PMCID: PMC1007391
- DOI: 10.1136/ard.35.4.333
Indomethacin serum concentrations in man. Effects of dosage, food, and antacid
Abstract
In the use of anti-inflammatory compounds, sustained serum levels are thought to be related to drug efficacy. This study shows that frequent clinical administration of indomethacin can result in sustained serum levels of the drug and that food and antacid may have important modifying effects on serum indomethacin concentrations. After oral ingestion by fasting subjects, indomethacin rapidly appeared in the serum, usually reaching peak concentrations in 30 to 90 minutes. Food delayed and decreased the mean peak level; antacid delayed the peak and slightly enhanced subsequent concentrations. With multiple dose schedules plateau levels were reached after 24 hours. When a total daily dose of 150 mg was given as 25 mg every 4 hours peak concentrations were the same but fluctuations were smaller and average concentrations were higher than with a dosage of 50 mg every 8 hours.
Similar articles
-
Clinical Pharmacokinetics of indomethacin.Clin Pharmacokinet. 1981 Jul-Aug;6(4):245-58. doi: 10.2165/00003088-198106040-00001. Clin Pharmacokinet. 1981. PMID: 7249487
-
Pharmacokinetic overview of indomethacin and sustained-release indomethacin.Am J Med. 1985 Oct 25;79(4C):3-12. doi: 10.1016/0002-9343(85)90510-8. Am J Med. 1985. PMID: 3904441 Review.
-
The effect of an antacid on the bioavailability of indomethacin.Eur J Clin Pharmacol. 1977 Aug 17;12(1):65-8. doi: 10.1007/BF00561407. Eur J Clin Pharmacol. 1977. PMID: 902677 Clinical Trial.
-
Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients.Br J Clin Pharmacol. 1996 Jun;41(6):513-6. doi: 10.1046/j.1365-2125.1996.03636.x. Br J Clin Pharmacol. 1996. PMID: 8799515 Free PMC article.
-
Effects of antacids on the clinical pharmacokinetics of drugs. An update.Clin Pharmacokinet. 1990 Mar;18(3):210-9. doi: 10.2165/00003088-199018030-00003. Clin Pharmacokinet. 1990. PMID: 1969784 Review.
Cited by
-
The effects of selected drugs, including chlorpromazine and non-steroidal anti-inflammatory agents, on polyclonal IgG synthesis and interleukin 1 production by human peripheral blood mononuclear cells in vitro.Clin Exp Immunol. 1989 May;76(2):252-7. Clin Exp Immunol. 1989. PMID: 2788047 Free PMC article.
-
Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.Clin Pharmacokinet. 1990 Jul;19(1):44-66. doi: 10.2165/00003088-199019010-00004. Clin Pharmacokinet. 1990. PMID: 2199127 Review.
-
Chronopharmacokinetic study of a prolonged release form of indomethacin.Eur J Clin Pharmacol. 1983;24(5):667-70. doi: 10.1007/BF00542219. Eur J Clin Pharmacol. 1983. PMID: 6873148 Clinical Trial.
-
Pros and cons of the tuberculosis drugome approach--an empirical analysis.PLoS One. 2014 Jun 27;9(6):e100829. doi: 10.1371/journal.pone.0100829. eCollection 2014. PLoS One. 2014. PMID: 24971632 Free PMC article.
-
Clinical Pharmacokinetics of indomethacin.Clin Pharmacokinet. 1981 Jul-Aug;6(4):245-58. doi: 10.2165/00003088-198106040-00001. Clin Pharmacokinet. 1981. PMID: 7249487
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources